Biofil Chemicals & Pharmaceuticals Share Price

Biofil Chemicals

CMP as on 20-Oct-21 15:29

₹ 63.65
-2.75 -4.14%

Open

₹ 66.40

Turnover (lac)

₹ 21

Prev. Close

₹ 66.40

Day's Vol (shares)

₹ 33,396

Day's Range (₹)

₹ 62.85
₹ 67.65

CMP as on20-Oct-21 15:30

₹ 63.70
-3 -4.5%

Open

₹ 67.50

Turnover (lac)

₹ 38

Prev. Close

₹ 66.70

Day's Vol (shares)

₹ 14,932

Day's Range

₹ 63.70
₹ 67.50

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 04-Aug-2021 - -
BIOFIL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 ,inter alia, to consider and approve With reference to above captioned subject and in terms of Regulation 29 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015, we would like to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Friday 13th August 2021 , at Registered Office of the Company to transact the following matters:- 1. To consider and approve the Un-audited Financial Result of the Company for the 1st Quarter ended on 30th June 2021 along with limited review report thereon. 2. To consider matters relating to the ensuing Annual General Meeting. With reference to the above-mentioned subject and as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of the Directors of the Company in their meeting (No. 03/2021-22) held on today i.e. Friday 13th day of August 2021, following matters have been inter alia transacted along with other routine businesses:- Pursuant to the provisions of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we are hereby enclosing Un-Audited Financial Results together with Limited Review Report thereon for the quarter 30th June 2021 duly approved by the Board of Directors of the Company at its meeting held today i.e. on Friday, 13th August 2021 at the Registered office of the Company. Copy of Unaudited Financial Results along with Limited Review Report is enclosed with this letter (searchable PDF mode). Further, copy of Un-Audited Financial Statements shall also be submitted in XBRL mode within 24 hours from the conclusion of Board Meeting Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) read with sub-para 7 of Para A of Part A of Schedule III to the Listing Regulations, this is to inform you that Board of Directors in their meeting held on, Friday, 13th Day of August, 2021, approved the appointment of Shri Ramesh Shah (Managing Director) as Chairman of the Board and Company with effect from 13th August, 2021. (As per BSE Announcement Dated on 13/8/2021)
Board Meeting - 22-Jun-2021 - -
BIOFIL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2021 ,inter alia, to consider and approve With reference to the above captioned subject and in terms of Regulation 29 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors (Serial No. 02/2021-22) of the Company is scheduled to be held on Wednesday, 30th June, 2021 at the Registered Office of the Company to inter alia consider and approve the following businesses with the permission of the Chair: 1. To consider and approve Audited Financial Results for the Quarter as well as Year ended on 31st March, 2021 along with Auditors Report thereon. 2. Any other routine businesses with the permission of the chair. Dear Sir/Madam, With reference to the above captioned subject, we would like to inform you that Board of Directors of the Company in their meeting (Serial No. 02/2021-22) held on today i.e., Wednesday, 30th day of June, 2021, has approved following matters along with other routine businesses 1. Approval of Audited Financial Results of the Company for the quarter as well as year ended 31st March, 2021 along with Audit Report thereon, Statement of assets and liabilities, Cash Flow Statement, Segment Reporting & declaration by the Managing Director of Company pursuant to second proviso of Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. Appointment of Shri Satish Beohar (DIN: 09220291) as an Additional Director as well as Independent Director of the Company for a term of five years from 30th June, 2021 to 29th June, 2026 subject to approval by the members at ensuing Annual General Meeting. (As Per BSE Announcement dated on 30.06.2021)
Board Meeting - 05-Feb-2021 - -
BIOFIL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2021 ,inter alia, to consider and approve With reference to above captioned subject and in terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we would like to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Friday 12th February 2021, at Registered Office of the Company. Pursuant to the provisions of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we are hereby enclosing Un-Audited Financial Results together with Limited Review Report thereon for the quarter and nine months ended on 31st December, 2020 duly approved by the Board of Directors of the Company at its meeting held today i.e. on Friday, 12th February, 2021. Copy of Unaudited Financial Results is enclosed with this letter (searchable PDF mode). Further, copy of Un-Audited Financial Statements shall also be submitted in XBRL mode (Excel Template provided by Exchange) within 24 hours from the conclusion of Board Meeting. The aforesaid results will be published in one Hindi (vernacular) and widely circulated English Newspaper. The Results shall also be uploaded on website of Stock Exchanges i.e. www.bseindia.com and www.nseindia.com and on the website of the Company at www.biofilgroup.net. With reference to the above-mentioned subject, we would like to inform that Board of the Directors of the Company in their meeting (No. 04/2020-2021) held today i.e. Friday 12th day of February 2021, has approved Un-Audited Financial Result and Limited Review Report thereon for the Quarter and nine months ended on 31st December, 2020. Copy of result being sent separately The meeting of Board of Directors was commenced at 4.30 p.m. and concluded at 5.50 p.m. This is for your information and record (As Per BSE Announcement dated on 12.02.2021)
Board Meeting - 04-Nov-2020 - -
BIOFIL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2020 ,inter alia, to consider and approve With reference to above captioned subject and in terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we would like to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday 11th November 2020, at Registered Office of the Company to transact the following matters:- 1. To consider and approve the Un-Audited Financial Results of the Company for the quarter as well as half year ended on 30th September, 2020 along with statement of assets and liabilities and limited review report. 2. Any other matter with the permission of chair. With reference to the above-mentioned subject, we would like to inform that Board of the Directors of the Company in their Meeting (Serial No. 03/2020-2021) held on today i.e. Wednesday 11th November 2020, has inter alia, transacted following matters along with other routine businesses:- 1. Un-Audited Financial Result of the Company for the Quarter and Half year ended 30th September, 2020 along with Statement of Assets and Liabilities, Cash Flow Statement, Segment Reporting and Limited Review Report thereon. 2. Approval of revised Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (UPSI). (As Per BSE Announcement Dated 11.11.2020(
Open ZERO Brokerage Demat Account